{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:36:39Z","timestamp":1789662999203,"version":"4.0.1"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Variations in perioperative dexamethasone dosing are common in brain metastasis resection, but their impact on patient outcomes remains unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the association between perioperative dexamethasone dosing and patient outcomes, focusing on overall survival (OS) and progression-free survival (PFS).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective multicenter comparative effectiveness study used data collected from January 2010 to December 2023. Patients with symptomatic brain metastases undergoing primary surgical resection at 7 neurological centers in Germany and 1 in Austria and who had complete records of perioperative dexamethasone dosing were included. Propensity score matching (PSM) was used to control for confounders. Analysis was conducted from March to June 2024.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Cumulative perioperative dexamethasone administration over 27 days, dichotomized at 122 mg using maximally selected rank statistics.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was OS. Secondary outcomes included extracranial PFS (ecPFS) and intracranial PFS (icPFS) as well as incidence of wound revision surgery after brain metastasis resection. Hazard ratios (HRs) were calculated using Cox proportional hazards models.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 1064 patients were included in the analysis. The median (IQR) age was 64 (56-72) years, with 489 female patients (49%) and 541 male patients (51%). Non\u2013small cell lung cancer (NSCLC) was the most common tumor entity (564 patients [53%]), followed by breast cancer (146 patients [14%]) and melanoma (138 patients [13%]). After PSM, patients receiving cumulative dexamethasone doses less than 122 mg had a median OS of 19.1 (95% CI, 15.2-22.4) months compared with 12.0 (95% CI, 9.1-14.7) months for those receiving 122 mg or more (P<\/jats:italic>\u2009=\u2009.002). Multivariable analysis showed an independent association between higher cumulative dexamethasone doses and reduced OS (HR, 1.40; 95% CI, 1.18-1.66; P<\/jats:italic>\u2009&amp;lt;\u2009.001). Secondary analyses demonstrated consistent findings with icPFS and ecPFS and a dose-response association between cumulative dexamethasone and hazard for death.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, higher cumulative perioperative dexamethasone was associated with reduced OS, icPFS, and ecPFS in patients undergoing brain metastasis resection. These findings suggest that stricter dosing protocols could improve outcomes. Prospective trials are warranted to confirm these associations and guide evidence-based practice.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.4689","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:30:38Z","timestamp":1744385438000},"page":"e254689","source":"Crossref","is-referenced-by-count":14,"title":["Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection"],"prefix":"10.1001","volume":"8","author":[{"given":"David","family":"Wasilewski","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Araceli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Regensburg Medical Center, Regensburg, Germany"},{"name":"Wilhelm-Sander Neuro-Oncology Unit, University Regensburg Medical Center, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Rafaelian","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medicine Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Demetz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Asey","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunc-Faik","family":"Ersoy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (Evangelisches Klinikum Bethel), Medical School, Bielefeld University, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Dauth","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Neumeister","sequence":"additional","affiliation":[{"name":"Centre of Neuro-Oncology, Department of Neurosurgery, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Peukert","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"P\u00f6ser","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bukatz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Shaked","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Jelgersma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Fr\u00fch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Misch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capper","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Institute of Neuropathology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"Department of Radiation Oncology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Frost","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Department of Infectious Diseases and Pulmonary Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Department of Hematology, Oncology and Tumor Immunology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Department of Hematology, Oncology and Tumor Immunology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Senft","sequence":"additional","affiliation":[{"name":"Centre of Neuro-Oncology, Department of Neurosurgery, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Krenzlin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ringel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pohrt","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Clinical Epidemiology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno S.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gempt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kerschbaumer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Freyschlag","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (Evangelisches Klinikum Bethel), Medical School, Bielefeld University, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dubinski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medicine Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Freiman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medicine Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Ole","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Regensburg Medical Center, Regensburg, Germany"},{"name":"Wilhelm-Sander Neuro-Oncology Unit, University Regensburg Medical Center, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Proescholdt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Regensburg Medical Center, Regensburg, Germany"},{"name":"Wilhelm-Sander Neuro-Oncology Unit, University Regensburg Medical Center, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vajkoczy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Onken","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"1","key":"zoi250205r1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis.","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"zoi250205r2","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab119","author":"Sammons","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"10","key":"zoi250205r3","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro Oncol"},{"issue":"11","key":"zoi250205r4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"5","key":"zoi250205r5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.prro.2021.04.002","article-title":"Radiation therapy for brain metastases: a systematic review.","volume":"11","author":"Garsa","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"zoi250205r6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1634\/theoncologist.2018-0306","article-title":"Upfront surgical resection of melanoma brain metastases provides a bridge toward immunotherapy-mediated systemic control.","volume":"24","author":"Alvarez-Breckenridge","year":"2019","journal-title":"Oncologist"},{"issue":"12","key":"zoi250205r7","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/cncr.33459","article-title":"Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.","volume":"127","author":"Bander","year":"2021","journal-title":"Cancer"},{"issue":"7","key":"zoi250205r8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/neuonc\/noy056","article-title":"Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.","volume":"20","author":"Arvold","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"zoi250205r9","doi-asserted-by":"publisher","first-page":"E607","DOI":"10.1093\/neuros\/nyz186","article-title":"Letter: when less is more: dexamethasone dosing for brain tumors.","volume":"85","author":"Lim-Fat","year":"2019","journal-title":"Neurosurgery"},{"issue":"2","key":"zoi250205r10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls.","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"zoi250205r11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40425-018-0371-5","article-title":"Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.","volume":"6","author":"Giles","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"3","key":"zoi250205r12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11060-018-2761-4","article-title":"Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma.","volume":"137","author":"Dubinski","year":"2018","journal-title":"J Neurooncol"},{"issue":"2","key":"zoi250205r13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00415-020-09731-5","article-title":"Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis.","volume":"268","author":"Petrelli","year":"2021","journal-title":"J Neurol"},{"issue":"Pt 5","key":"zoi250205r14","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma.","volume":"139","author":"Pitter","year":"2016","journal-title":"Brain"},{"issue":"20","key":"zoi250205r15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"32","key":"zoi250205r16","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient.","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi250205r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9553","article-title":"Effectiveness of immune checkpoint inhibition vs chemotherapy in combination with radiation therapy among patients with non-small cell lung cancer and brain metastasis undergoing neurosurgical resection.","volume":"5","author":"Wasilewski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi250205r19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/bimj.200310030","article-title":"Assessment of optimal selected prognostic factors.","volume":"46","author":"Lausen","year":"2004","journal-title":"Biometrical J"},{"issue":"3","key":"zoi250205r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"mice: Multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"zoi250205r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114202","article-title":"\u201cSymptomatic\u201d melanoma brain metastases: A call for clear definitions and adoption of standardized tools.","volume":"208","author":"Le Rhun","year":"2024","journal-title":"Eur J Cancer"},{"issue":"4","key":"zoi250205r22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/WNL.44.4.675","article-title":"Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.","volume":"44","author":"Vecht","year":"1994","journal-title":"Neurology"},{"key":"zoi250205r23","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/j.wneu.2021.12.067","article-title":"Practice variation in perioperative steroid dosing for brain tumor patients: an international survey.","volume":"159","author":"Jessurun","year":"2022","journal-title":"World Neurosurg"},{"key":"zoi250205r24","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npab039","author":"Mistry","year":"2021","journal-title":"Neurooncol Pract"},{"key":"zoi250205r25","doi-asserted-by":"publisher","DOI":"10.3171\/2021.4.JNS204127","author":"Medikonda","year":"2021","journal-title":"J Neurosurg"},{"issue":"2","key":"zoi250205r26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000597","article-title":"Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status.","volume":"8","author":"Camy","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"5","key":"zoi250205r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100620","article-title":"Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases.","volume":"3","author":"Sudmeier","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"zoi250205r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100900","article-title":"Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.","volume":"4","author":"\u00c1lvarez-Prado","year":"2023","journal-title":"Cell Rep Med"},{"key":"zoi250205r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114202","article-title":"\u201cSymptomatic\u201d melanoma brain metastases: a call for clear definitions and adoption of standardized tools.","volume":"208","author":"Le Rhun","year":"2024","journal-title":"Eur J Cancer"},{"issue":"7","key":"zoi250205r30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002261","article-title":"Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer.","volume":"9","author":"Maslov","year":"2021","journal-title":"J Immunother Cancer"},{"key":"zoi250205r31","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03360-9","article-title":"Determinants of activity and efficacy of anti-PD1\/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.","author":"Javier","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"zoi250205r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25459","article-title":"Use of first-line immune checkpoint inhibitors and association with overall survival among patients with metastatic melanoma in the Anti-PD-1 era.","volume":"5","author":"Lamba","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi250205r17","unstructured":"GPA Index. Accessed March 3, 2025. https:\/\/brainmetgpa.com\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2832545\/wasilewski_2025_oi_250205_1743691930.16649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:30:40Z","timestamp":1744385440000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2832545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.4689","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}